Literature DB >> 16797282

Quality of life and psychosocial factors in renal transplant recipients.

V S Shah1, A Ananth, G K Sohal, W Bertges-Yost, A Eshelman, R K Parasuraman, K K Venkat.   

Abstract

An ideal method for quality of life (QOL) assessment in renal transplant recipients (RTR) has not yet been determined. Present assessments of QOL in RTR are lengthy, cumbersome to administer, and difficult to interpret. We used a previously validated single question QOL scale score (QLS) that directly asks about the patients' overall assessment of their QOL; "Considering all parts of my life-physical, emotional, social, spiritual, and financial--over the past 2 days the quality of my life has been ... ". The QLS ranges from 0 ("very bad") to 10 ("excellent"). Patients were contacted prior to their routine office visit when they were free of acute medical problems. Fifty RTR participated. Psychosocial and medical variables included the Beck Depression Inventory, Illness Effects Questionnaire, Multidimensional Scale of Perceived Social Support, time since transplant, age, creatinine, hemoglobin, and albumin levels. Of the patients, 64% were African-American and 48% were women; 94% of patients had a score>5. Mean QLS was 7.5+/-2.3. Perception of a better QOL correlated with less perception of depression and illness effects and with perception of greater social support and satisfaction with life (all P<.05). Perception of QOL did not correlate with age, time since transplantation, creatinine, hemoglobin or albumin levels. We concluded that QLS is a quick tool to measure subjective QOL in RTR for correlation with psychosocial factors of interest in this group. These studies should be replicated in larger multiethnic populations.

Entities:  

Mesh:

Year:  2006        PMID: 16797282     DOI: 10.1016/j.transproceed.2006.03.027

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Recruitment of live donors by candidates for kidney transplantation.

Authors:  Peter P Reese; Judy A Shea; Jeffrey S Berns; Maureen K Simon; Marshall M Joffe; Roy D Bloom; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

2.  Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients.

Authors:  Noritaka Kawada; Toshiki Moriyama; Naotsugu Ichimaru; Ryoichi Imamura; Isao Matsui; Yoshitsugu Takabatake; Yasuyuki Nagasawa; Yoshitaka Isaka; Yasuyuki Kojima; Yukito Kokado; Hiromi Rakugi; Enyu Imai; Shiro Takahara
Journal:  Clin Exp Nephrol       Date:  2009-04-08       Impact factor: 2.801

3.  Prevalence and prognostic factors for erectile dysfunction in renal transplant recipients.

Authors:  Jaime A Wong; Joseph Lawen; Bryce Kiberd; Waleed K Alkhudair
Journal:  Can Urol Assoc J       Date:  2007-11       Impact factor: 1.862

4.  What clinical pharmacology means to us.

Authors:  S Malhotra; N Shafiq
Journal:  Mens Sana Monogr       Date:  2006-01

5.  Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients.

Authors:  Yuri Battaglia; Luigi Zerbinati; Giulia Piazza; Elena Martino; Michele Provenzano; Pasquale Esposito; Sara Massarenti; Michele Andreucci; Alda Storari; Luigi Grassi
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241

6.  Anxiety and Depression: A Comparison between Living and Cadaveric Renal Transplant Recipients.

Authors:  Z Parsaei Mehr; M Hami; Z Moshtagh Eshgh
Journal:  Int J Organ Transplant Med       Date:  2011

Review 7.  Chronic Kidney Disease, Spirituality and Religiosity: A Systematic Overview with the List of Eligible Studies.

Authors:  Nicola Luigi Bragazzi; Giovanni Del Puente
Journal:  Health Psychol Res       Date:  2013-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.